Increasing cAMP antagonizes hypertrophic response to angiotensin II without affecting Ras and MAP kinase activation in vascular smooth muscle cells

FEBS Letters

Volumn 397, Issue 1, 1996, Pages 89-92

  Takahashi, Tomosaburo ^a   Kawahara, Yasuhiro ^a   Okuda, Masanori ^a   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; cAMP; Hypertrophy; MAP kinase; Ras; Vascular smooth muscle cell

Indexed keywords

ADHESIN; ANGIOTENSIN; BUCLADESINE; CYCLIC AMP; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVATION; HYPERTROPHY; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTO ONCOGENE; RAT; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; BUCLADESINE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL ADHESION MOLECULES; CELLS, CULTURED; CYCLIC AMP; CYTOSKELETAL PROTEINS; DNA; ENZYME ACTIVATION; FORSKOLIN; MUSCLE, SMOOTH, VASCULAR; PAXILLIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; RAS PROTEINS; RATS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030580349     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(96)01145-3     Document Type: Article

References (23)

1. [1] Geisterfer, A.A.T., Peach, M.J. and Owens, G.K. (1988) Circ. Res. 62, 749-756.
2. [2] Berk, B.C., Vekshtein, V., Gordon, H.M. and Tsuda, T. (1989) Hypertension 13, 305-314.
3. [3] Okuda, M., Kawahara, Y. and Yokoyama, M. (1996) Am. J. Physiol. (in press).
4. [4] Schieffer, B., Paxton, W.G., Chai, Q., Marrero, M.B. and Bernstein, K.E. (1996) J. Biol. Chem. 271, 10329-10333.
5. [5] Eguchi, S., Matsumoto, T., Motley, E.D., Utsunomiya, H. and Inagami, T. (1996) J. Biol. Chem. 271, 14169-14175.
6. [6] Tsuda, T., Kawahara, Y., Ishida, Y., Koide, M., Shii, K. and Yokoyama, M. (1992) Circ. Res. 71, 620-630.
7. [7] Kawahara, Y., Sunako, M., Tsuda, T., Fukuzaki, H., Fukumoto, Y. and Takai, Y. (1988) Biochem. Biophys. Res. Commun. 150, 52-59.
8. [8] Naftilan, A.J., Gilliland, G.K., Eldridge, C.S. and Kraft, A.S. (1990) Mol. Cell. Biol. 10, 5536-5540.
9. [9] Naftilan, A.J., Pratt, R.E. and Dzau, V.J. (1989) J. Clin. Invest. 83, 1419-1424.
10. [10] Okuda, M., Kawahara, Y., Nakayama, I., Hoshijima, M. and Yokoyama, M. (1995) FEBS Lett. 368, 343-347.
11. [11] Leduc, I. and Meloche, S. (1995) J. Biol. Chem. 270, 9, 4401-4404.
12. [12] Turner, C.E., Pietras, K.M., Taylor, D.S. and Molloy, C.J. (1995) J. Cell Sci. 108, 333-342.
13. [13] Nilsson, J. and Olsson, A.G. (1984) Atherosclerosis 53, 77-82.
14. [14] Loesberg, C., Van Wijk, R., Zandbergen, J., Van Aken, W.G., Van Mourik, J.A. and De Groot, P.G. (1985) Exp. Cell Res. 160, 117-125.
15. [15] Jonzon, B., Nilsson, J. and Fredholm, B.B. (1985) J. Cell. Physiol. 124, 451-456.
16. [16] Graves, L.M., Bornfeldt, K.E., Raines, E.W., Potts, B.C., Macdonald, S.G., Ross, R. and Krebs, E.G. (1993) Proc. Natl. Acad. Sci. USA 90, 10300-10304.
17. [17] Graves, J.D., Campbell, J.S. and Krebs, E.G. (1995) Ann. N.Y. Acad. Sci. 766, 320-343.
18. [18] Gunther, S., Alexander, R.W., Atkinson, W.J. and Gimbrone, M.A., Jr. (1982) J. Cell Biol. 92, 289-298.
19. [19] Nakayama, I., Kawahara, Y., Tsuda, T., Okuda, M. and Yokoyama, M. (1994) J. Biol. Chem. 269, 15, 11628-11633.
20. [20] Kariya, K., Kawahara, Y., Araki, S., Fukuzaki, H. and Takai, Y. (1989) Atherosclerosis 80, 143-147.
21. [21] Garg, U.C. and Hassid, A. (1989) J. Clin. Invest. 83, 1774-1777.
22. [22] Itoh, H., Pratt, R.E. and Dzau, V.J. (1990) J. Clin. Invest. 86, 1690-1697.
23. [ 23] Clark, E.A. and Brugge, J.S. (1995) Science 268, 233-239.